Public Policy Resources

Share

The Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act (H.R. 842/S. 339)

February 3, 2025

Multi-Cancer Screening Tests Can Catch Cancer Early

Earlier screening for cancer is important because when detected at later stages, treatments are more limited, and outcomes are generally poorer. Medicare enrollees should have access to multi-cancer screening tests when the benefit is clinically shown. Multi-cancer early detection tests are innovative tests that have the potential to detect multiple cancers through the use of a single test. Several private and academic entities are currently developing multi-cancer early detection (MCED) blood-based tests. Published data indicate that some of these tests can screen for many different types of cancers at the same time, including some rare cancers.  

PDF icon mced_factsheet_119th_congress_feb_2025.pdf

Related Resources

ACS CAN Policy Brief: Multi-Cancer Early Detection Tests

August 26, 2024

Multi-Cancer Early Detection Tests (MCEDs) are simple blood tests that can screen for many types of cancer at once. Congress must seize the opportunity to ensure these cutting-edge tests can be covered under Medicare once they are FDA-approved and proven to have clinical benefit. Doing so has the potential to save lives and revolutionize the way we detect cancer.

Read more